Stress hormones, not impaired insulin signaling, may underlie obesity-related diabetes, according to Rutgers research.

VK2809 found that those on the medicine saw statistically significant reductions in liver fat, meeting the primary endpoint.

Patients receiving VK2809 demonstrated statistically significant reductions in liver fat at Week 12, which was the primary endpoint in VOYAGE.  Importantly, patients receiving VK2809 continued to ...

Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-β) Agonist, was Well-tolerated with Significant Reductions in ...